The Real Thymosin Alpha-1 Price Tag in 2026 — With and Without Insurance

Thymosin Alpha-1 at a glance:

• Drug class: Immunomodulatory peptide
• Route: subcutaneous injection
• Typical frequency: twice weekly in approved hepatitis B regimens
• Half-life: approximately 2 hours
• Cash price (US): varies by country; not commercially available in US

Thymosin Alpha-1 pricing is one of those topics where the official "list price" and what people actually pay are two different conversations. The cash price runs varies by country; not commercially available in US. Below we walk through the real options.

Thymosin Alpha-1 Cash Price

Without insurance, Thymosin Alpha-1 runs varies by country; not commercially available in US in the US market.

That number is the starting point — what you actually pay depends on:

• Insurance status (commercial, Medicare, Medicaid, uninsured)
• Manufacturer savings programs (where applicable)
• Discount cards (GoodRx, Cost Plus Drug, manufacturer cards)
• Telehealth bundling (some platforms include the drug in a flat monthly fee)
• Pharmacy choice (chain vs independent vs mail-order)

Insurance Coverage

Coverage for Thymosin Alpha-1 depends on the specific plan and the indication being treated. For FDA-approved indications, prior authorization is the most common gate. For off-label use, coverage is generally not available.

The pattern across the GLP-1 / metabolic medication space is: coverage for diabetes is widespread, coverage for weight loss is improving but still inconsistent, and coverage for any off-label use is rare.

Manufacturer Programs

Thymosin Alpha-1 doesn't have an FDA-approved manufacturer in the US, so traditional savings programs don't apply.

Cash-Pay and Direct-from-Manufacturer Options

Several manufacturers have introduced direct-to-consumer cash channels for their GLP-1 products in response to coverage gaps. These can lower the cash price meaningfully — see our guide to getting GLP-1 medications for current options.

Total Cost Over a Year

A monthly price of varies by country; not commercially available in US translates to roughly $10,800-$18,000 per year out of pocket without insurance. That's a real number to plan around — many programs that look attractive at $200/month for the first three months reset to full price after the introductory window.

For weight management, the relevant question is whether to plan around long-term use; for this compound, the duration question depends on the indication.

Comparing to Alternatives

Approved chronic hepatitis B therapies in the US include entecavir and tenofovir. Some of those alternatives may be cheaper, covered when Thymosin Alpha-1 isn't, or just better-suited for a particular case. See our cost comparison pages: linked above.

Bottom Line

Thymosin Alpha-1 cost decisions deserve a real planning session — not a back-of-envelope guess. The annual numbers add up fast.

Frequently Asked Questions

Related Reading

• Thymosin Alpha-1 Explained: How It Works and Who It's For
• Thymosin Alpha-1 Side Effects: The Complete List and How to Handle Them
• Does Thymosin Alpha-1 Really Work? An Evidence-Based Results Review
• Thymosin Alpha-1 Protocols: A Research-Based Overview (Not a Recommendation)
• What Is BPC-157? Everything You Should Know Before Starting
• Is BPC-157 Safe? An Honest Look at the Side-Effect Profile

Sources

• Goldstein AL et al. Thymosin β4: A Multi-Functional Regenerative Peptide. Annals NY Acad Sci 2012;1269:1.
• Sosne G et al. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy. Expert Opinion 2015;15:663.
• Sikiric P et al. Stable Gastric Pentadecapeptide BPC 157 — Major Wound-Healing Properties. Pharmaceuticals 2020;13:155.

Pricing changes frequently. The numbers on this page reflect publicly available information as of 2026-04-29 and should be verified at the point of purchase.